Related Experiment Video
Updated: Jun 21, 2026

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and
1Department of Applied Therapeutics, Faculty of Pharmacy, Kuwait University, Safat, 13110, Kuwait. masocha@hsc.edu.kw
Abstract:
LPS activates microglia, which are normally maintained in a quiescent state by CD200-CD200 receptor (CD200R) interaction. MAC-1 (a microglia marker) mRNA expression was increased in mice brains up to 1 year post LPS administration (i.p.). Minocycline treatment did not prevent LPS (5 mg/kg)-induced increase in MAC-1 mRNA but reduced that induced by 0.1 mg/kg LPS. CD200R mRNA decreased starting at 4 h, whereas CD200 mRNA increased at 4 h and decreased at 1 year post LPS inoculation. Thus, LPS-induced changes in CD200-CD200R equilibrium might keep microglia chronically activated. Minocycline does not effectively inhibit microglia activation induced by high-dose LPS.
Insights
Lipopolysaccharide (LPS) can lead to chronic microglia activation by disrupting CD200-CD200 receptor (CD200R) balance. Minocycline is ineffective at inhibiting high-dose LPS-induced microglia activation.
Area of Science:
- Neuroimmunology
- Microglia biology
- Neuroinflammation
Background:
- Microglia are immune cells in the brain, typically quiescent.
- CD200-CD200 receptor (CD200R) interaction maintains microglial quiescence.
- Lipopolysaccharide (LPS) is a potent activator of microglia.
Purpose of the Study:
- To investigate the long-term effects of LPS on microglia activation.
- To examine the role of the CD200-CD200R pathway in LPS-induced neuroinflammation.
- To evaluate the efficacy of minocycline in mitigating LPS-induced microglia activation.
Main Methods:
- Mice were administered LPS (intraperitoneally).
- MAC-1 mRNA expression (a microglia marker) was measured over time.
- CD200 and CD200R mRNA levels were analyzed.
- Minocycline treatment was administered at different LPS doses.
Main Results:
- MAC-1 mRNA expression remained elevated up to 1 year post-LPS.
- CD200R mRNA decreased, while CD200 mRNA initially increased then decreased post-LPS.
- Minocycline failed to prevent MAC-1 mRNA increase with high-dose LPS (5 mg/kg).
- Minocycline partially reduced MAC-1 mRNA increase with low-dose LPS (0.1 mg/kg).
Conclusions:
- LPS disrupts the CD200-CD200R equilibrium, potentially causing chronic microglia activation.
- High-dose LPS-induced microglia activation is not effectively inhibited by minocycline.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
07:31Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
Published on: August 23, 2022